drugset / Trial / NCT02976337

Effect of High-dose Naloxone Following Third Molar Extraction

NCT02976337

Phase 2 Completed 23 enrolled mads u werner University of Kentucky · collab
RandomizedCrossoverQuadruple-blindBasic science

Summary

Recent studies have focused on the role of endogenous opioids on central sensitization. Central sensitization is known to be impaired or altered in chronic pain conditions, as fibromyalgia or chronic tension headache. Animal studies have shown reinstatement of mechanical hypersensitivity following naloxone administration after resolution of an injury. This suggests latent sensitization. In the present study, the investigators hypothesize that a high-dose target-controlled naloxone infusion (total dose: 3.25 mg/kg) can reinstate pain and hyperalgesia 6-8 weeks after a unilateral primary open groin hernia repair procedure. The investigators aim to show that latent sensitization is present in humans and is modulated by endogenous opioids.

Timeline

Start
2017-10-12
Primary completion
2023-11-27
Completion
2023-12-27

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule 3.25 mg/kg Intravenous

Indications

No indication recorded.